Literature DB >> 2369356

Cataract surgery in nanophthalmic eyes.

R J Brockhurst1.   

Abstract

Cataract surgery in nanophthalmic eyes may be complicated by postoperative uveal effusion. Evidence is presented that prophylactic lamellar scleral resection with decompression of the vortex veins, performed 2 months or more prior to cataract extraction, may reduce the incidence of this severe complication. A randomized study to determine the benefit of such prophylaxis is advocated.

Entities:  

Mesh:

Year:  1990        PMID: 2369356     DOI: 10.1001/archopht.1990.01070090067041

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  The Value and Caveats of Interpreting Small Case Series: Implications for Patient Care.

Authors:  Richard K Parrish; Ta Chen Chang; Sarah L Duncan Powers
Journal:  Am J Ophthalmol       Date:  2019-11-05       Impact factor: 5.258

2.  Foveal avascular zone area measurements with optical coherence tomography angiography in patients with nanophthalmos.

Authors:  Ali Demircan; Ceren Yesilkaya; Cigdem Altan; Zeynep Alkin; Dilek Yasa; Ebru Demet Aygit; Damla Bektasoglu
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

3.  Nanophthalmos.

Authors:  Siamak Moradian; Azadeh Kanani; Hamed Esfandiari
Journal:  J Ophthalmic Vis Res       Date:  2011-04

4.  Survey of microphthalmia in Japan.

Authors:  Sachiko Nishina; Daijiro Kurosaka; Yasuhiro Nishida; Hiroyuki Kondo; Yuri Kobayashi; Noriyuki Azuma
Journal:  Jpn J Ophthalmol       Date:  2012-02-23       Impact factor: 2.447

5.  Outcomes of combined phacoemulsification, anterior vitrectomy, and sclerectomy in nanophthalmic eyes with glaucoma.

Authors:  Xintong Fan; Jiajian Wang; Qilian Sheng; Ruyi Zhai; Xiangmei Kong
Journal:  Eye (Lond)       Date:  2022-04-05       Impact factor: 3.775

6.  Implantation of a double iris-claw intraocular lens in an aphakic nanophthalmic eye.

Authors:  Filiz Avsin Ozdemir Sarioglu; Yelda Yildiz Tasci; Bengi Ece Kurtul; Sefer Ogün Boluk
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.